Alcon Laboratories, Inc. (ACL) Directors Say Novartis Corporation (NVS) Bid Grossly Inadequate
1/20/2010 6:25:37 AM
More...
|
Novartis Corporation (NVS) (JOBS) May Nudge up Bid for Rest of Alcon Laboratories, Inc. (ACL)
1/13/2010 6:42:00 AM
More...
|
Novartis Corporation (NVS) (JOBS) Seeks to Buy Rest of Alcon Laboratories, Inc. (ACL) for $39 Billion
1/4/2010 6:21:17 AM
More...
|
Alcon Laboratories, Inc. (ACL) Posts 5.9 Percent Sales Growth for Third Quarter
10/28/2009 10:16:35 AM
More...
|
Potentia Pharmaceuticals, Inc. Enters into Licensing and Purchase Option Agreements with Alcon Laboratories, Inc. (ACL); Deal Provides Path for Alcon to Acquire Potentia
10/23/2009 6:42:16 AM
More...
|
Alcon Laboratories, Inc. (ACL) to Acquire Swiss Biotechnology Firm, ESBATech for $589 Million
9/14/2009 7:05:15 AM
More...
|
Alcon Laboratories, Inc. (ACL) Discontinues Development of Anecortave Acetate for Intraocular Pressure Reduction
7/6/2009 10:33:21 AM
More...
|
Alcon Laboratories, Inc. (ACL) Achieves Required Ownership in WaveLight to Initiate Squeeze-out
5/13/2009 7:29:36 AM
More...
|
Alcon Laboratories, Inc. (ACL) Signs Contract with LCA-Vision for 75 ALLEGRETTO WAVE(R) Excimer Lasers
3/10/2009 1:52:00 PM
More...
|
Alcon Laboratories, Inc. (ACL) Names Insider Kevin Buehler as New CEO
1/9/2009 6:35:13 AM
More...
|
|